New workflow validated on Dynamic Devices Lynx® delivers scalable plasmid DNA extraction from Midi to Maxi-prep volumes ...

The University of Nevada nominates five exceptional undergraduates for the prestigious Barry Goldwater Scholarship. Get to ...

A new DNA immunotherapy, Elenagen, doubled survival (13 to 25+ months) for tough ovarian cancers when added to chemotherapy, with fewer side effects.

NYSE-listed Charles River Laboratories International, Inc. is selling some of its assets in two separate transactions.

Investing.com -- Charles River Laboratories International (NYSE:CRL) shares gained 3.5% in premarket trading Wednesday after the company announced plans to divest its CDMO and Cell Solutions ...

Announces Signing of Definitive Agreements to Divest the CDMO and Cell Solutions Businesses and Certain European Discovery Services Assets –– Updates 2026 Financial Guidance –WILMINGTON, ...

Nanocarriers enhance peptide and oligonucleotide therapy by improving stability, bioavailability, and targeted delivery for ...

Last year, APW science students put BioSpherix Xvivo Ed® to use in Bio 103, designed to enhance classroom experiments and offer an ideal entry point into real-world lab ...

Researchers from Tokyo Metropolitan University have created a new molecule which carries DNA into biological cells, to treat or vaccinate against illnesses. Many existing options rely on molecules ...

Franzen wants to move DuPont from the materials sector, where it is considered a specialty chemicals company, to somewhere in ...

This important study demonstrates that a peri-nuclear actomyosin network, present in some types of human cells, facilitates kinetochore-spindle attachment of chromosomes in unfavorable locations - ...

Human MAP1LC3B (LC3B) binds proteins involved in autophagy and other cellular processes using a degenerate four-residue short linear motif known as the LC3-interacting region (LIR). Biochemical and ...